• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Jasper Therapeutics, Inc. - Class A Common Stock (NQ:JSPR)

    1.840 +0.095 (+5.44%)
    Streaming Delayed Price Updated: 1:00 PM EST, Nov 28, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Jasper Therapeutics, Inc. - Class A Common Stock

    < Previous 1 2 3 4 5 6 7 8 Next >
    News headline image
    Jasper Shares Climb As FDA Grants Fast Track Status To Immunodeficiency Disease Candidate ↗
    Jasper Therapeutics (NASDAQ: JSPR) announced that its lead asset JSP191 has received fast track designation from the U.S. Food and Drug Administration (FDA) for the treatment of patients with severe... 
    Via Benzinga
    News headline image
    Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday ↗
    Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX... 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
      
    Via Benzinga
    News headline image
    Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday ↗
    Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 263% to $2.73 on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown... 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Jasper Therapeutics Reveals Treatment of First Patient in the Phase 1/2 Study of JPS191 for Fanconi Anemia ↗
    Jasper Therapeutics, Inc. (NASDAQ: JSPR) dosed first patient in the Phase 1/2 clinical study of its drug candidate JPS191 as a conditioning agent in the treatment of Fanconi Anemia. 
    Via Benzinga
    News headline image
    66 Biggest Movers From Yesterday ↗
    Gainers Better Therapeutics, Inc. (NASDAQ: BTTX) shares surged 120.4% to close at $2.01 on Monday following a 5% drop on Friday. SoundHound AI, Inc. (NASDAQ: SOUN) shares surged... 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
    Gainers Ocular Therapeutix (NASDAQ:OCUL) shares moved upwards by 12.3% to $4.01 during Friday's after-market session. The company's market cap stands at $307.7 million. 
    Via Benzinga
    News headline image
    Jasper Therapeutics Presented Updated Data from Phase 1 Clinical Trial of JSP191 ↗
    Jasper Therapeutics, Inc., (NASDAQ: JSPR) announced updated efficacy, safety and pharmacokinetic data from its Phase 1 clinical trial of JSP191, in older patients with myelodysplastic syndromes (MDS)... 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Gainers Statera BioPharma (NASDAQ:STAB) stock rose 23.6% to $0.9 during Friday's pre-market session. The company's market cap stands at $32.4 million. InVivo... 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Lows On Thursday ↗
    On Thursday, 236 companies hit new 52-week lows. 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Lows On Wednesday ↗
    On Wednesday, 90 companies set new 52-week lows. Areas of Significance In Today's 52-Week Lows: The company with the largest market cap to set a new 52-week low was... 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Lows On Wednesday ↗
    Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by... 
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2022 ↗
    Upgrades According to DA Davidson, the prior rating for Envestnet Inc (NYSE:ENV) was changed from Neutral to Buy. In the fourth quarter, Envestnet showed an EPS of $0.50, compared... 
    Via Benzinga
    News headline image
    Mid-Day Market Update: Crude Oil Down 1%; Inspira Technologies Shares Spike Higher ↗
    Midway through trading Thursday, the Dow traded down 0.18% to 35,691.63 while the NASDAQ fell 0.72% to 15,672.75. The S&P also fell, dropping 0.37% to 4,683.86. The U.S. has... 
    Via Benzinga
    Topics Stocks
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021 ↗
    Upgrades For Nektar Therapeutics (NASDAQ: 
    Via Benzinga
    News headline image
    52 Biggest Movers From Yesterday ↗
    Gainers ION Geophysical Corporation (NYSE: IO) shares surged 29.8% to settle at $0.5969. Synaptogenix, Inc. (NASDAQ: SNPX) climbed 29.4% to close at $10.09. Synaptogenix... 
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2021 ↗
    Upgrades For Coterra Energy Inc (NYSE:CTRA), Piper... 
    Via Benzinga
    News headline image
    52 Weeks High And Low Article ↗
    Stocks that Broke Yearly Lows Tuesday Morning During Tuesday's morning trading, 87 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Highs And Lows: 10x... 
    Via Benzinga
    News headline image
    The Secret To Successful Investing In Biotech ↗
    Have you ever had a stock jump 30%, 50% or 100% in one day? 
    Via Talk Markets
    News headline image
    56 Biggest Movers From Yesterday ↗
    Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares jumped 84% to close at $4.95 on Thursday after the company signed an exclusive summary distribution agreement... 
    Via Benzinga
    News headline image
    46 Biggest Movers From Yesterday ↗
    Gainers Valneva SE (NASDAQ: VALN) shares surged 39.8% to close at $39.21 on Monday after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial... 
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2021 ↗
    Upgrades For Iridium Communications Inc (NASDAQ:IRD... 
    Via Benzinga
    News headline image
    The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs ↗
    Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market rally and some sector-specific news.... 
    Via Benzinga
    News headline image
    51 Biggest Movers From Friday ↗
    Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 38.1% to close at $4.75 on Friday after declining around 15% on Thursday. The company recently announced it... 
    Via Benzinga
    News headline image
    Mid-Morning Market Update: Markets Open Higher; Goldman Sachs Beats Q3 Expectations ↗
    Following the market opening Friday, the Dow traded up 0.80% to 35,190.31 while the NASDAQ rose 0.28% to 14,864.73. The S&P also rose, gaining 0.58% to 4,463.81. The U.S. has... 
    Via Benzinga
    Topics Stocks
    News headline image
    44 Biggest Movers From Yesterday ↗
    Gainers Benessere Capital Acquisition Corp. (NASDAQ: BENER) shares jumped 66.5% to close at $0.4530 on Thursday. Grove, Inc. (NASDAQ: GRVI) gained 39.3% to close at $6.98 after... 
    Via Benzinga
    News headline image
    Why Jasper Therapeutics Stock Is Falling Today ↗
    Jasper Therapeutics Inc (NASDAQ: JSPR) is trading lower Thursday amid profit taking after the stock rallied roughly 120% on Wednesday. Jasper Therapeutics surged ... 
    Via Benzinga
    Accelerating R&D Activities in Breast Cancer Therapy Market Fueling Optimism for Development of Advanced Treatments
    Palm Beach, FL – October 14, 2021 – FinancialNewsMedia.com News Commentary – The breast cancer drugs market, which has been steadily growing over the past few years, is projected to continue this trend... 
    Via FinancialNewsMedia
    < Previous 1 2 3 4 5 6 7 8 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.